Home › Funds › Renaissance Technologies › UTHR

Renaissance Technologies position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Renaissance Technologies reported holding 1,675,899 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$908.2M, representing 1.24% of its reported portfolio and ranking #3 among its reported holdings. Renaissance Technologies has disclosed UTHR holdings in 55 of the last 55 reported quarters, going back to Q1 2013.

Latest position (Q3 2026)1.68M sh
Reported value held$908.15M
Portfolio Weight1.24%
First reportedQ1 2013
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Renaissance Technologies's UTHR position evolved

Renaissance Technologies first disclosed a stake in UTHR in Q1 2013 at 323,175 shares (US$19.7M). The position peaked in Q1 2026 at 1,787,019 shares, worth US$1.06B. Across 55 filings, Renaissance Technologies increased the stake 27 time(s), trimmed it 26 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,675,899 shares valued at US$908.2M — a reduction of -32,840 shares quarter over quarter.. Notable position changes include a 99% trim in Q3 2014, a 7690% increase in Q4 2014, a 141% increase in Q1 2015.

Quarter by quarter

QuarterSharesValueChange
Q1 2013 323.18K $19.67M New
Q2 2013 590.38K $38.86M Add
Q3 2013 440.78K $34.76M Reduce
Q4 2013 224.28K $25.36M Reduce
Q1 2014 287.94K $27.07M Add
Q2 2014 252.48K $22.34M Reduce
Q3 2014 2.38K $306.00K Reduce
Q4 2014 185.24K $23.99M Add
Q1 2015 446.50K $76.99M Add
Q2 2015 811.58K $141.17M Add
Q3 2015 866.78K $113.76M Add
Q4 2015 552.08K $86.46M Reduce
Q1 2016 474.58K $52.88M Reduce
Q2 2016 404.30K $42.82M Reduce
Q3 2016 390.10K $46.06M Reduce
Q4 2016 421.20K $60.41M Add
Q1 2017 506.20K $68.53M Add
Q2 2017 837.60K $108.66M Add
Q3 2017 1.27M $149.18M Add
Q4 2017 1.46M $216.36M Add
Q1 2018 1.53M $172.35M Add
Q2 2018 1.56M $176.08M Add
Q3 2018 1.94M $248.61M Add
Q4 2018 2.20M $239.23M Add
Q1 2019 2.24M $263.12M Add
Q2 2019 3.04M $237.38M Add
Q3 2019 3.21M $256.18M Add
Q4 2019 3.54M $312.19M Add
Q1 2020 3.59M $340.44M Add
Q2 2020 3.73M $450.94M Add
Q3 2020 3.71M $374.61M Hold
Q4 2020 3.61M $547.55M Reduce
Q1 2021 3.21M $536.53M Reduce
Q2 2021 3.11M $558.00M Reduce
Q3 2021 3.03M $559.02M Reduce
Q4 2021 2.92M $630.35M Reduce
Q1 2022 2.77M $496.11M Reduce
Q2 2022 2.79M $658.28M Add
Q3 2022 2.55M $533.96M Reduce
Q4 2022 2.34M $651.98M Reduce
Q1 2023 2.23M $498.85M Reduce
Q2 2023 2.19M $482.83M Reduce
Q3 2023 2.25M $508.32M Add
Q4 2023 2.17M $477.21M Reduce
Q1 2024 2.15M $494.29M Reduce
Q2 2024 2.17M $692.75M Add
Q3 2024 2.16M $772.38M Reduce
Q4 2024 2.09M $737.22M Reduce
Q1 2025 2.11M $649.52M Add
Q2 2025 2.12M $608.92M Add
Q3 2025 2.17M $911.11M Add
Q4 2025 1.91M $930.29M Reduce
Q1 2026 1.79M $1.06B Reduce
Q2 2026 1.71M $925.85M Reduce
Q3 2026 1.68M $908.15M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 38 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), ASSETMARK, INC (US$325.2M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$247.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Renaissance Technologies held UTHR?

Renaissance Technologies has disclosed UTHR holdings in 55 of the last 55 reported quarters, going back to Q1 2013.

What is Renaissance Technologies's current position in UTHR?

As of Q3 2026, Renaissance Technologies holds 1.68M shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $908.15M, representing 1.24% of its reported portfolio and ranking #3.

Has Renaissance Technologies been buying or selling UTHR?

In the latest 13F filing (Q3 2026), Renaissance Technologies reduced its position in UTHR. The position peaked in Q1 2026 at 1.79M shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, ASSETMARK, INC, DEERFIELD MANAGEMENT COMPANY, L.P., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.